MRNS

Q: What is the price of Marinus Pharmaceuticals (MRNS) today?

A cotação de Marinus Pharmaceuticals (MRNS) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

Q: When does Marinus Pharmaceuticals (MRNS) pay dividends?

Marinus Pharmaceuticals (MRNS) did not pay dividends over the past year.

Q: Is Marinus Pharmaceuticals (MRNS) a good investment?

Atualmente, Marinus Pharmaceuticals (MRNS) está cotada a $ 0.00, com um P/L de -0.22, This represents a -415% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Marinus Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.22

p/bv

-0.47

DIVIDEND YIELD

0.00%

MRNS price

MRNS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment MRNS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals MRNS

review the fundamentals of Marinus Pharmaceuticals shares

P/E

-0.22

Sector: 10.48 Industry: 20.27

P/S (PSR)

1.00

Sector: 1.00 Industry: 1.31

P/BV

-0.47

Sector: 1.61 Industry: 3.93

DIVIDEND YIELD (DY)

0.00%

Sector: 0.40% Industry: 2.60%

ROA

-220.84%

Sector: 1.24% Industry: 7.21%

ROE

210.52%

Sector: 4.44% Industry: 20.89%

ROIC

-443.43%

Sector: -6.90% Industry: 17.44%

NET MARGIN

-100.00%

Sector: 1.84% Industry: 6.06%

GROSS MARGIN

90.15%

Sector: 38.86% Industry: 38.76%

OPERATING MARGIN

-100.00%

Sector: 5.63% Industry: 7.95%

EV/EBITDA

-0.26

Sector: 5.39 Industry: 11.07

EV/EBIT

-0.25

Sector: 6.78 Industry: 15.25

PRICE-TO-ASSETS

0.49

Sector: 0.77 Industry: 1.47

BVPS

-1.17

Sector: 10.09 Industry: 36.27

EPS

-2.46

Sector: 0.81 Industry: 6.39

EQUITY-TO-ASSETS RATIO

-1.05

Sector: 0.30 Industry: 0.39

LIABILITIES / ASSETS

2.05

Sector: 0.58 Industry: 0.72

CAGR REVENUE 5 YEARS

43.17%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

7.30%

Sector: - Industry: -

Fundamentals MRNS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AMZN	32.26	6.63	20.55%	0.00%	$ 2.93 T	12.22%
MELI	41.69	12.34	29.59%	0.00%	$ 83.26 B	6.91%
DIS	16.88	1.64	9.73%	1.17%	$ 189.44 B	11.54%
VZ	11.45	1.90	16.57%	5.86%	$ 198.56 B	12.46%
MCD	22.59	-152.46	-674.81%	2.63%	$ 196.06 B	31.62%
WMT	47.49	9.79	20.62%	0.73%	$ 1.04 T	3.07%
V	27.23	16.98	62.35%	0.79%	$ 605.38 B	51.68%
COST	52.39	13.96	26.64%	0.52%	$ 447.90 B	2.99%
NFLX	27.63	11.87	42.97%	0.00%	$ 369.47 B	28.52%
T	8.13	1.39	17.09%	4.41%	$ 178.59 B	17.47%
BABA	25.66	2.07	8.07%	1.43%	$ 325.08 B	8.90%
SBUX	79.98	-14.14	-17.68%	2.34%	$ 119.62 B	3.89%
HD	22.27	24.60	110.48%	2.91%	$ 315.23 B	8.60%
TGT	15.17	3.48	22.93%	3.66%	$ 56.24 B	3.54%
CMCSA	4.83	1.03	21.23%	5.20%	$ 90.86 B	15.00%
TBB	11.68	1.46	12.50%	5.61%	$ 171.43 B	11.99%
CMG	29.04	17.52	60.31%	0.00%	$ 42.17 B	11.96%
TMUS	20.40	3.85	18.87%	1.94%	$ 215.05 B	11.65%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

MRNS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Marinus Pharmaceuticals

Marinus Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

23 years

Founded: 2003

2014

Time since IPO - 12 years

72

Employees

Marinus Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $31.35 Millions, with shareholders equity totaling $-66.74 Millions.

The company employs approximately 72 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Marinus Pharmaceuticals Inc. reported $31.47 Millions in revenue, generating net income of $-140.50 Millions.

Key financial metrics include a P/E ratio of -0.22, a price-to-book (P/B) ratio of -0.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRNS.

Market cap

$ 31.35 Millions

Net worth

$ -66.74 Millions

$ -66,740,000.00

Assets

$ 63.62 Millions

$ 63,620,000.00

Total Shares Outstanding

57.00 Millions

57,000,000

Average Daily Trading Volume

$ 1.91 Million

$ 1,914,396.34

Sector

Services

Industry

Commercial Services

MRNS

MRNS revenue and profits

Financial Results MRNS

DRAG THE FRAME TO SEE MORE DATA

MRNS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

WSG - Wanda Sports Group

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-7.74%

P/BV

0.00

WMT - Walmart

$ 130.35 37,94% (12M)

P/E

47.49

0.73%

ROE

20.62%

P/BV

9.79

AMZN - Amazon

$ 265.82 25,76% (12M)

P/E

32.26

0.00%

ROE

20.55%

P/BV

6.63

COST - Costco Wholesale

$ 1,021.88 3,00% (12M)

P/E

52.39

0.52%

ROE

26.64%

P/BV

13.96

JD - JD.com

$ 31.49 --12,57% (12M)

P/E

15.68

3.23%

ROE

6.52%

P/BV

1.02

BABA - Alibaba

$ 134.78 2,38% (12M)

P/E

25.66

1.43%

ROE

8.07%

P/BV

2.07

WBA - Walgreens Boots Alliance

$ - -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

HD - Home Depot

$ 310.46 --14,80% (12M)

P/E

22.27

2.91%

ROE

110.48%

P/BV

24.60

WSG - Wanda Sports Group

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-7.74%

P/VP

0.00

WMT - Walmart

$ 130.35 37,94% (12 M)

P/L

47.49

0.73%

ROE

20.62%

P/VP

9.79

AMZN - Amazon

$ 265.82 25,76% (12 M)

P/L

32.26

0.00%

ROE

20.55%

P/VP

6.63

COST - Costco Wholesale

$ 1,021.88 3,00% (12 M)

P/L

52.39

0.52%

ROE

26.64%

P/VP

13.96

JD - JD.com

$ 31.49 --12,57% (12 M)

P/L

15.68

3.23%

ROE

6.52%

P/VP

1.02

BABA - Alibaba

$ 134.78 2,38% (12 M)

P/L

25.66

1.43%

ROE

8.07%

P/VP

2.07

WBA - Walgreens Boots Alliance

$ - -0,00% (12 M)

P/L

-1.76

4.17%

ROE

-80.35%

P/VP

1.42

HD - Home Depot

$ 310.46 --14,80% (12 M)

P/L

22.27

2.91%

ROE

110.48%

P/VP

24.60

Frequently Asked Questions

What is the price of Marinus Pharmaceuticals (MRNS) today?

A cotação de Marinus Pharmaceuticals (MRNS) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

When does Marinus Pharmaceuticals (MRNS) pay dividends?

Marinus Pharmaceuticals (MRNS) did not pay dividends over the past year.

Is Marinus Pharmaceuticals (MRNS) a good investment?

Atualmente, Marinus Pharmaceuticals (MRNS) está cotada a $ 0.00, com um P/L de -0.22, This represents a -415% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Marinus Pharmaceuticals (MRNS) stock?

You can buy Marinus Pharmaceuticals (MRNS) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol MRNS and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Marinus Pharmaceuticals (MRNS) yield today?

Over the past month, Marinus Pharmaceuticals (MRNS) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Marinus Pharmaceuticals (MRNS) hoje, o investimento total seria de $ 0.00, com base na cotação atual de $ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 0.00
Em 5 anos: $ 0.00
Em 10 anos: $ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MRNS

Marinus Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MRNS

review the fundamentals of Marinus Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Marinus Pharmaceuticals

Marinus Pharmaceuticals Inc.

United States

23 years

2014

72

PROFIT X PRICE MRNS

Financial Results MRNS

MRNS cash flow

Asset, Revenue and Profit Growth - MRNS

MRNS balance sheet

WSG - Wanda Sports Group

WMT - Walmart

AMZN - Amazon

COST - Costco Wholesale

JD - JD.com

BABA - Alibaba

WBA - Walgreens Boots Alliance

HD - Home Depot

WSG - Wanda Sports Group

WMT - Walmart

AMZN - Amazon

COST - Costco Wholesale

JD - JD.com

BABA - Alibaba

WBA - Walgreens Boots Alliance

HD - Home Depot

Frequently Asked Questions